In Italy, acetylcholinesterase inhibitors (AChEIs) (i.e. donepezil, rivastigmine and galantamine) and memantine (NMDA receptor antagonist) are the approved drugs for treating Alzheimer’s disease (ADDs) and are reimbursed by the Italian NHS. The gene discussed is ACHE; the disease is Alzheimer disease.